An orthotopic model of human pancreatic cancer in severe combined immunodeficient mice: potential application for preclinical studies.

Mohammad, R M; Al-Katib, A; Pettit, G R; Vaitkevicius, V K; Joshi, U; Adsay, V; Majumdar, A P; Sarkar, F H

Mohammad, R M; Al-Katib, A; Pettit, G R; Vaitkevicius, V K; Joshi, U; Adsay, V; Majumdar, A P; Sarkar, F H.

Affiliation

Mohammad RM; Division of Hematology and Oncology, Wayne State University School of Medicine, Karmanos Cancer Institute, Detroit, Michigan 48201, USA.

Clin Cancer Res ; 4(4): 887-94, 1998 Apr.

Article in En | MEDLINE | ID: mdl-9563882

Subject(s)

Adenocarcinoma/drug therapy; Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Pancreatic Neoplasms/drug therapy; Adenocarcinoma/pathology; Animals; Deoxycytidine/administration & dosage; Deoxycytidine/analogs & derivatives; Disease Models, Animal; Female; Mice; Mice, Inbred ICR; Mice, SCID; Oligopeptides/administration & dosage; Pancreatic Neoplasms/pathology; Transplantation, Heterologous; Gemcitabine

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Adenocarcinoma / Antineoplastic Combined Chemotherapy Protocols Limits: Animals Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 1998 Document type: Article Affiliation country: United States Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links